Cystic fibrosis drug is not cost effective, says NICE.
London.
Anne
A
Gulland
D000627:Aminophenols / Q000191:economics / Q000627:therapeutic use*; D000631:Aminopyridines / Q000191:economics / Q000627:therapeutic use*; D052117:Benzodioxoles / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D015363:Quinolones / Q000191:economics / Q000627:therapeutic use*; D019141:Respiratory System Agents / Q000191:economics / Q000627:therapeutic use*
D000627:Aminophenols; D000631:Aminopyridines; D052117:Benzodioxoles; D015363:Quinolones; D019141:Respiratory System Agents; C545203:ivacaftor; C569105:lumacaftor